Crossmark

Safety and Diagnostic Utility of Brain Biopsy and Metagenomics in Decision-Making for Patients with Inborn Errors of Immunity (IEI) and Unexplained Neurological Manifestations

Crossref DOI link: https://doi.org/10.1007/s10875-025-01878-y

Published Online: 2025-04-16

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maimaris, Jesmeen

Payne, Julia

Roa-Bautista, Adriel

Breuer, Judith

Storey, Nathaniel

Morfopoulou, Sofia

Bamford, Alasdair

D’Arco, Felice

Gilmour, Kimberly

Aquilina, Kristian

Hassell, Jane

Hacohen, Yael

Silva, Adikarige H.D.

Merve, Ashirwad

Jacques, Thomas S.

Rao, Kanchan

Chiesa, Robert

Amrolia, Persis

Silva, Juliana

Braggins, Helen

Xu-Bayford, Jinhua

Goldblatt, David

Worth, Austen

Booth, Claire

Ip, Winnie

Qasim, Waseem

Kusters, Maaike

Kaliakatsos, Marios

Brown, Julianne R

Elfeky, Reem
Funding

Funding for this research was provided by:

National Institute for Health and Care Research

Brain Tumour Charity (GN-000707)

Olivia Hodson Cancer Fund

Cancer Research UK
License Information

Text and Data Mining valid from 2025-04-16

Version of Record valid from 2025-04-16
More Information

Article History

Received: 24 June 2024

Accepted: 31 March 2025

First Online: 16 April 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below